82 



HANDBOOK OF PHYSIOLOGY 



CIRCULATION I 



24. CzERNY, A. Versuche uber bluteindickung und ihre 

 folgen. Arch. exp. Pathol, u Pkarmakol. 34: 268-280, 1894. 



25. Davidsohn, I., AND K. Stern. Disturbance of hemostasis 

 in rabbits treated with polyvinylpyrrolidone (PVP). 

 J. Mt. Sinai Hospital New York 24: 777-792, 1957. 



26. Dick, M. VV., E. Warweg, and M. Andersch. Acacia 

 in the treatment of nephrosis. J. A.M. A. 105: 654-657, 



'935- 



27. Enostrand, L., and B. Aberg. Excretion of intravenously 

 administered dextran. Lancet 1 : 1071-1073, 1950. 



28. Figueroa, L., and F, J. Lavieri. The use of pectin and 

 other agents to prevent shock. Surg. Gynec. & Obst. 78: 

 600-605, 1944. 



29. Fleming, J. W., W. H, Cargill, and W. L. Bloom. 

 Effects of intravenous administration of dextran on renal 

 function. Proc. Soc. Exper. Biol. & A fed. 79: 604-606, 1952. 



30. Fleming, J. W., and W. L. Bloom. Further observations 

 on the hemodynamic effect of plasma volume expansion 

 by dextran. J. Clin. Invest. 36: 1233, ^951' 



31. Fowler, N. O., R. Shabetai, D. Anderson, and J. R. 

 Braunstein. Some circulatory effects of experimental 

 hypovolemic anemia. Am. Heart J. 60:551-561, i960. 



32. Fowler, N. O., R. H. Franch, and W. L. Bloom. 

 Hemodynamic effects of anemia with and without plasma 

 volume expansion. Circulation Res. 4:319, 1956. 



33. Fowler, N. O., W. L. Bloom, and J. .\. Ward. Hemo- 

 dynamic effects of hypervolemia with and without 

 anemia. Circulation Res. 6: 163, 1958. 



34. Frawley, J. P., C. P. Artz, and J. M. How.\rd. Plasma 

 retention and urinary excretion of dextran and modified 

 fluid gelatin in combat casualties. Surgery 37: 384-391, 



1955- 



35. Frommer, J. The pathogenesis of reticulo-endothelial 

 foam cells. Effect of polyvinylpyrrolidone on liver of the 

 mouse. Am. J. Path. 32: 433, 1956. 



36. Gall, E. A., W. A. Altemeier, L. Schiff, D. L. Hamil- 

 ton, H. Braitnstein, J. GuisEFFi, and D. G. Freeman. 

 Liver lesions following intravenous administration of 

 polyvinylpyrrolidone (PVP). Am. J. Clin. Path. 23: 1187- 



1198, 1953- 



37. Gordon, H., L. J. Hoge, and H. Lawson. Gelatin as a 

 substitute for blood after experimental hemorrhage. Am. J. 

 M. Sc. 204: 4-1 1, 1942. 



38. GowDEY, C. W., AND I. E. YouNG. Caidioienal effects of 

 large infusions of dextran in dogs. Canad. J. Biochem. & 

 Physiol. 32 : 559, 1 954. 



39. Gray, I. Metabolism of plasma expanders studied with 

 carbon-! 4-labeled dextran. Am. J. Physiol. 174: 462-466, 



1953- 



40. Gray, I., and E. J. Pulaski. Metabolism of plasma 

 substitutes II. Oxypolygelatin. Proc. Soc. Exper. Biol. & 

 Med. 78: 421, 1951. 



41. Gray, I., P. K. Siiteri, and E. J. Pulaski. Metabolism of 

 plasma substitute I, Dextran (Macrodex). Proc. Soc. 

 Exper. Biol. & Med. 77: 626-627, '95'- 



42. Greenman, L., E. B. Fergus, F. M. Mateer, F. .\. 

 Weigand, and T. S. Danowski. Blood, plasma, serum 

 and urine changes following hyperoncotic and iso-oncotic 

 dextran. J. Appl. Physiol. 6; 79, 1953. 



43. Gronwall, a., and B. Inoelman. Dextran as a substitute 

 for plasma. Nature 155: 45, 1945. 



44. Cropper, A. L., L. G. Raisz, and W. H. Amsp.\cher. 

 Plasma expanders. Surg. Gynec. & Obst. 95: 521-542, 1952. 



45. Handford, S. \V., C. McC. Smythe, J. P. Gilmore, 

 R. S. Leopold, R. H. K.\than, and H. G. Arm. Glycerol 

 pectate for plasma volume replacement and expansion : 

 an experimental study. J. .ippl. Physiol. 7: 553-576, 



1954-55- 



46. Hardwicke, J., C. R. Ricketts, and J. R. Squire. 

 Effect of dextran of various molecular sizes on erythrocyte 

 sedimentation rate. Nature 166: 988, 1950. 



47. Hartm.\n, F. VV. Tissue changes following the use of 

 plasma substitutes. A.M. A. Arch. Surg. 63: 728-738, 1951. 



48. Hehre, E. J., AND T. W. Sery. Dextran-splitting ana- 

 erobic bacteria from the human intestine. J. Bact. 63 ; 

 424-426, 1952. 



49. Hoffman, W. S., and D. D. Kozoll. The fate of intra- 

 venously injected gelatin in human subjects. J. Clin. 

 Invest. 25: 575-585, 1946. 



50. Hog an, J. J. The intravenous use of colloidal (gelatin) 

 solutions in shock. J. A.M. A. 64: 721, 1915. 



51. Horvath, S. M., L. H. Hamilton, G. B. Spurr, E. B. 

 Allbaugh, and B. K. Hutt. Plasma expanders and 

 bleeding times. J. Appl. Physiol. 7: 614-616, 1954-55. 



52. Howard, J. M., C. T. Teng, and R. K. Loeffler. 

 Studies of dextrans of various molecular sizes. Ann. Surgery 



143: 369- >956. 



53. Hueper, W. C. Macromolecular substances as patho- 

 genic agents. A.M. A. Arch. Path. 33: 267-290, 1942. 



54. Hueper, W. C. Organic lesions produced by polyvinyl 

 alcohol in rats and rabbits. A.M..^. .Arch. Path. 28: 510-531, 



>939- 



55. Hueper, \V. C. Experimental carcinogenic studies in 

 macromolecular chemicals. I. Neoplastic reactions in rats 

 and mice after parenteral introduction of poly\'inylpyr- 

 rolidones. Cancer 10: 8, 1957. 



56. Hueper, W. C, J. VV. Landsberg, and L. C. Eskridge. 

 The effects of intravenous and intraperitoneal introduc- 

 tion of polyvinyl alcohol solutions upon the blood. 

 J. Pharmacol. & Exper. Therap. 70: 201, 1940. 



57. Ivy, a. C., H. Greengard, I. F. Stein, F. S. Grodins, 

 and D. F. Dutton. The effect of various blood substitutes 

 in resuscitation after an otherwise fatal hemorrhage. 

 Surg. Gynec. & Obst. 76: 85-90, 1943. 



58. Jackson, R. L., and L. Frayser. The effect of acacia on 

 the blood. J. Pharmacol. & Exper. Therap. 65: 440-452, 



'939- 



59. Jacobaeus, LI. Studies on the effect of dextran on the 

 coagulation of blood. Acta med. Scandinav. suppl. 322 p. 



3-103. 1957- 



60. Jacobson, S. D., and C. J. Smyth. Gelatin as a substitute 

 for plasma. A.M. A. Arch. Int. Med. 74: 254-257, 1944. 



61. Jaenike, J. R., AND C. Waterhouse. Metabolic and 

 hemodynamic changes induced by the prolonged admin- 

 istration of dextran. Circulation 11 : 1-13, 1955. 



62. James, J., G. Gordillo, and J. Metcoff. Effects of 

 infusion of hyperoncotic dextran in children with the 

 nephrotic syndrome. J. Clin. Invest. 33: 1346-1357, 1954. 



63. Jenkins, L. B,, F. E. Kredel, and W. M. McCord. 

 Evaluation of polyvinylpyrrolidone as a plasma expander. 

 A.M. A. Arch. Surg. 72: 612, 1956. 



64. Justus, D. VV., R. VV. Cornett, and J. D. Hatcher. A 

 humoral influence on cardiovascular adjustments to acute 

 and chronic post-hemorrhagic anemia in dogs. Circulation 

 Res. 5: 207, 1957. 



